Menu
Home » Living with prostate cancer

Living with prostate cancer

Thanks to advances in diagnostics and treatments, you may live with your prostate cancer for many years. Depending on the stage of your prostate cancer, your chances of living for over 5 years after your diagnosis are over 95%.

However, being diagnosed with any kind of cancer can be overwhelming. You might be left with lots of questions about your options. Your medical team can advise you on their recommendations, but it’s important you consider what is important to you.

Book your consultation

This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Read more.

Mr Alan Doherty: Do only old men get prostate cancer?
00:35
Playlist
Prostate Cancer
Book your consultation
SUMMARY
"Mr. Alan Doherty (Consultant Urologist, The Focal Therapy Clinic): Prostate cancer is rare under 40 but occurs in all age groups above this. Since it can take time to become aggressive, age is an important factor in treatment decisions. Understanding the risks and timelines can help patients make informed choices about their care. Alan Doherty - https://www.thefocaltherapyclinic.co.uk/about-us/our-consultants/mr-alan-doherty/ Localised prostate cancer - https://www.thefocaltherapyclinic.co.uk/blog/what-is-localised-prostate-cancer/ Focal Therapy - https://www.thefocaltherapyclinic.co.uk/focal-therapy/

TRANSCRIPT
Mr. Alan Doherty: ### **Prostate Cancer & Age** - **Prostate cancer can occur in all men over 40**, but it is **extremely rare under this age**. - The **majority of cases** are seen in **older men**, as the disease is **more common with aging**. ### **Why Age Matters in Prostate Cancer** - **Prostate cancer often progresses slowly**, meaning that **age is a key factor in treatment decisions**. - In **younger men**, treatment may be prioritized to ensure **long-term cancer control**. - In **older men**, a more conservative approach, such as **active surveillance**, may be considered when cancer is **slow-growing and unlikely to impact lifespan**. ### **Takeaway** **Age plays a crucial role** in determining **when and how prostate cancer should be treated**, balancing **cancer control with quality of life**.

This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Read more.
Mr Marc Laniado: How many people are diagnosed with prostate cancer every year?
00:22
Playlist
Prostate Cancer
Book your consultation
SUMMARY
"Mr. Marc Laniado (Consultant Urologist, The Focal Therapy Clinic): Around 55,000 men are diagnosed with prostate cancer annually in the UK, marking a 40% increase since the 1990s. With cases expected to rise by another 15% in the coming years, awareness and early detection remain critical in improving outcomes. Marc Laniado - https://www.thefocaltherapyclinic.co.uk/about-us/our-consultants/mr-marc-laniado/ How long can you live with prostate cancer without treatment - https://www.thefocaltherapyclinic.co.uk/blog/how-long-can-you-live-with-prostate-cancer-without-treatment/

TRANSCRIPT
Mr. Marc Laniado: ### **Prostate Cancer Diagnosis Trends in the UK** - **Around 55,000 men are diagnosed with prostate cancer every year in the UK**. - The number of cases has **increased by approximately 40% since the 1990s**. - Projections suggest a **further 15% increase in diagnoses over the next few years**. ### **Why Are Cases Increasing?** - **Improved awareness and screening** lead to **earlier detection**. - **An aging population** contributes to the rise in cases. - **Lifestyle and environmental factors** may also play a role. As **more men are diagnosed**, it’s crucial to **focus on early detection, personalized treatment options, and maintaining quality of life**.

This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Read more.
Mr Alan Doherty: Is prostate cancer a 'good' cancer to get?
00:52
Playlist
Prostate Cancer
Book your consultation
SUMMARY
"Mr. Alan Doherty (Consultant Urologist, The Focal Therapy Clinic): Not all prostate cancers are life-threateningonly those that have learned to spread. If caught early, prostate cancer can be cured, allowing for effective treatment and long-term health. Early detection remains key to successful outcomes. Mr. Alan Doherty - https://www.thefocaltherapyclinic.co.uk/about-us/our-consultants/mr-alan-doherty/ Early symptoms of prostate cancer - https://www.thefocaltherapyclinic.co.uk/blog/the-early-symptoms-of-prostate-cancer/ 00:00 Common Fears & Misconceptions Introductory thoughts on how the term cancer triggers certain emotional and visual responses based on personal experience or media. 00:16 Understanding Cancers Variability Clarifies that cancer covers a wide spectrumfrom slow-growing types that may do little to aggressive forms that metastasize early. 00:34 When Cancer Is Not Immediately Lethal Emphasizes that only cancers that can spread pose a significant threat, and those that havent may be curable if caught early. 00:42 Opportunity for Cure Reassures that early detection allows for effective treatment, underscoring that early-stage types of prostate cancer can often be cured.

TRANSCRIPT
Mr. Alan Doherty: ### **Understanding Prostate Cancer & Its Risks** When you were told you had **prostate cancer**, it likely triggered **fears and assumptions** about what might happen next. This reaction is often based on: - **Personal experiences** (knowing someone with cancer). - **Reading about cancer** in the media. - **General perceptions of cancer as a life-threatening disease**. ### **Not All Prostate Cancers Are the Same** - **Some prostate cancers remain slow-growing for years** and may never cause harm. - **Other, more aggressive cancers can spread early** and require immediate treatment. ### **What Makes a Cancer Life-Threatening?** - A **cancer becomes dangerous when it has learned to spread**. - **If your cancer hasn’t spread yet**, it is **not immediately life-threatening**. - This means that **if detected early, prostate cancer can often be cured**. ### **Key Takeaway** **Early diagnosis provides an opportunity for cure**, so understanding **your cancer type and treatment options** is essential for making the right decisions.

This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Read more.
Dr Christos Mikropoulos: What is the prognosis for prostate cancer?
00:26
Playlist
Prostate Cancer
Book your consultation
SUMMARY
Dr. Christos Mikropoulos (Oncologist, The Focal Therapy Clinic): Early diagnosis is key in prostate cancer. When caught early, patients are often cured and have a normal life expectancy. However, late diagnosis still allows for long-term control but not a cure, making timely screening essential. Dr. Christos Mikropoulos - https://www.thefocaltherapyclinic.co.uk/about-us/our-consultants/dr-christos-mikropoulos/ early symptoms of prostate cancer - https://www.thefocaltherapyclinic.co.uk/blog/the-early-symptoms-of-prostate-cancer/ Book your consultation - https://www.thefocaltherapyclinic.co.uk/contact/

TRANSCRIPT
Dr. Christos Mikropoulos: ### **Why Early Diagnosis Matters in Prostate Cancer** The key to **successful prostate cancer treatment** is **early diagnosis**. - If prostate cancer is **diagnosed at an early stage**, the **outcome is excellent**. - **Patients can be cured**, and their **life expectancy remains normal**. ### **What Happens with Late Diagnosis?** - Even if diagnosed later, we can **still control prostate cancer for many years**. - However, in **advanced cases, a complete cure is no longer possible**. ### **Takeaway** To maximize **treatment success**, it is crucial to: - Undergo **regular PSA testing and MRI scans**. - Detect prostate cancer **before it spreads**. **Early detection saves lives** and improves **treatment outcomes significantly**.

This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Read more.
Mr Alan Doherty: What are the symptoms of prostate cancer?
00:40
Playlist
Prostate Cancer
Book your consultation
SUMMARY
Mr. Alan Doherty (Consultant Urologist, The Focal Therapy Clinic): Early-stage prostate cancer usually has no symptoms. Once it spreads, it can cause bone pain, fractures, or kidney issues if lymph nodes are affected. This highlights the importance of early detection and regular screening. Mr. Alan Doherty - https://www.thefocaltherapyclinic.co.uk/about-us/our-consultants/mr-alan-doherty/ Early symtoms of prostate cancer - https://www.thefocaltherapyclinic.co.uk/blog/the-early-symptoms-of-prostate-cancer/ where does prostate cancer spread - https://www.thefocaltherapyclinic.co.uk/blog/where-does-prostate-cancer-spread-to/

TRANSCRIPT
Mr. Alan Doherty: ### **Does Prostate Cancer Cause Symptoms?** In **most cases, early-stage prostate cancer has no symptoms**. - When the cancer is **contained within the prostate**, it is usually **small and does not press on the urethra** (the water pipe passing through the prostate). - Because of this, **men often don’t experience significant symptoms in the early stages**. ### **When Symptoms Appear** Prostate cancer **only causes noticeable symptoms once it spreads**: - **Bone pain & fractures** – If the cancer spreads to the bones. - **Kidney pain & urinary issues** – If cancer spreads to the **lymph nodes** and blocks structures like the ureters. Since **early prostate cancer is usually silent**, **regular PSA testing and MRI scans** are essential for early detection and treatment.

This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Read more.
Mr Marc Laniado: What is a prostate cancer lesion
00:31
Playlist
Prostate Cancer
Book your consultation
SUMMARY
Mr. Marc Laniado (Consultant Urologist, The Focal Therapy Clinic): A lesion is an abnormal area in the prostate, but not all lesions are tumors. Some may be benign (non-cancerous), while others are cancerous. Proper evaluation through imaging and biopsy is essential for accurate diagnosis and treatment planning.

TRANSCRIPT
Mr. Marc Laniado: You might have a **lesion** in your prostate, which simply means an **abnormal area**. - You could have **one lesion, two, three, or even more**. - A **tumor is a specific type of lesion**, meaning that **all tumors are lesions, but not all lesions are tumors**. ### **What Does This Mean for You?** - Some **lesions may be benign (non-cancerous)** and are **nothing to worry about**. - If you have multiple lesions, **only one may be a tumor**, while the others may be **completely harmless**. Understanding the difference between **lesions and tumors** is crucial in **determining the best course of action** for prostate health.

This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Read more.
Dr Christos Mikropoulos: What is advanced prostate cancer
00:28
Playlist
Prostate Cancer
Book your consultation
SUMMARY
Dr. Christos Mikropoulos (Oncologist, The Focal Therapy Clinic): Advanced prostate cancer can be locally advanced or metastatic. Locally advanced cancer spreads to lymph nodes or seminal vesicles, while metastatic cancer spreads to bones or other organs. Understanding the stage of cancer is crucial in determining the best treatment approach. Dr. Christos Mikropoulos - https://www.thefocaltherapyclinic.co.uk/about-us/our-consultants/dr-christos-mikropoulos/ Focal therapy - https://www.thefocaltherapyclinic.co.uk/focal-therapy/ Where does prostate cancer spread to - https://www.thefocaltherapyclinic.co.uk/blog/where-does-prostate-cancer-spread-to/

This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Read more.
Mr Marc Laniado: What is the prostate and what does it do
00:28
Playlist
Prostate Cancer
Book your consultation
SUMMARY
Mr. Marc Laniado (Consultant Urologist, The Focal Therapy Clinic): The prostate gland surrounds the urethra and plays a key role in semen production. It nourishes sperm and aids ejaculation, but it is not essential for urinary control or erectile function. Understanding its role helps men make informed decisions about prostate health and treatment options. Marc Laniado - https://www.thefocaltherapyclinic.co.uk/about-us/our-consultants/mr-marc-laniado/ What is a prostate - https://www.thefocaltherapyclinic.co.uk/blog/what-is-a-prostate/ Website: https://www.thefocaltherapyclinic.co.uk LinkedIn: linkedin.com/company/the-focal-therapy-clinic/ Facebook: facebook.com/TheFocalTC Telephone: +44 (0) 207 036 8870 #ProstateHealth #MensHealth #ProstateFunction #FocalTherapy #Urology #ProstateCancer

TRANSCRIPT
Mr. Marc Laniado: The **prostate gland** is located **just below the bladder, in front of the rectum**, and it **surrounds the urethra**. ### **What Is the Function of the Prostate?** - It is **about the size of a walnut** in most men. - The primary role of the prostate is to **produce semen**, which **nourishes sperm** and helps them fertilize an egg. - It also plays a minor role in **ejaculation and orgasm**. While the prostate is **important for reproductive function**, it is **not essential for urinary control or erectile function**, which is why **focal therapy or prostate removal can be performed when needed**.

This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Read more.
Mr Raj Nigam explains what the treatment options are for prostate cancer
02:35
Playlist
Prostate Cancer
Book your consultation
SUMMARY
Mr. Raj Nigam (Consultant Urologist, The Focal Therapy Clinic): Prostate cancer is classified as localized, locally advanced, or advanced. Focal therapy is suitable for early localized cases, with treatment options including HIFU, cryotherapy, and NanoKnife. Choosing the right treatment depends on cancer stage and individual patient factors. Mr Raj Nigam - https://www.thefocaltherapyclinic.co.uk/about-us/our-consultants/mr-raj-nigam/ treatment options - https://www.thefocaltherapyclinic.co.uk/living-with-prostate-cancer/treatment-options/ book a consultation - https://www.thefocaltherapyclinic.co.uk/contact/ stages of prostate cancer - https://www.thefocaltherapyclinic.co.uk/blog/stages-of-prostate-cancer 00:00 Introduction: Assessing Prostate Cancer Stage 00:05 Step One: Localized vs. Spread Cancer 00:12 Prostate Cancer Stages Overview 00:13 Stage 1: Localized Prostate Cancer (All Treatments Possible) 00:20 Stage 2: Locally Advanced Prostate Cancer (Beyond the Capsule) 00:35 Stage 3: Advanced/Metastatic Prostate Cancer (Disease Control Focus) 00:50 Focal Therapy for Localized Prostate Cancer 01:07 Benefits of Focal Therapy: Minimally Invasive & Precise 01:36 HIFU: High-Intensity Focused Ultrasound (No Cuts or Scalpels) 01:43 Cryotherapy: Freezing the Tumor Through the Perineum 01:54 NanoKnife: Electroporation to Destroy Cancer Cells 02:16 Strong 5-Year Data Supporting NanoKnife (Australia) 02:19 Summary: Targeted Treatment, Preserved Quality of Life Website: https://www.thefocaltherapyclinic.co.uk LinkedIn: linkedin.com/company/the-focal-therapy-clinic/ Facebook: facebook.com/TheFocalTC Telephone: +44 (0) 207 036 8870 #FocalTherapy #ProstateCancer #HIFU #Cryotherapy #NanoKnife #MensHealth

TRANSCRIPT
Mr. Raj Nigam: The first step in managing prostate cancer is to determine **whether it is localized or has spread**. ### **Prostate Cancer Stages** 1. **Localized Prostate Cancer** - The cancer is **completely confined to the prostate**. - **All treatment options remain available**, including **focal therapy, radical prostatectomy, and radiotherapy**. 2. **Locally Advanced Prostate Cancer** - The cancer has **spread outside the prostate capsule**. - It may have **reached the seminal vesicles** or **nearby lymph nodes**. - Treatment is usually **whole-gland options like surgery or radiotherapy**. 3. **Advanced (Metastatic) Prostate Cancer** - The cancer has spread to **other organs or bones**. - Treatment focuses on **disease control rather than cure**. ### **Focal Therapy for Localized Prostate Cancer** For **early-stage prostate cancer**, focal therapy offers a **minimally invasive alternative** to radical treatments. **Three focal therapy options are now accepted:** 1. **HIFU (High-Intensity Focused Ultrasound)** - Delivered **through the rectum**, with **no cuts or scalpels**. 2. **Cryotherapy** - **Freezes the tumor** within the prostate. - Delivered **through the perineum**, the same route as biopsies. 3. **NanoKnife (Irreversible Electroporation)** - Uses **electrical pulses to destroy cancer cells**. - Delivered **through the perineum** like cryotherapy. - Supported by **strong 5-year data from Australia**. Focal therapy offers a **targeted treatment approach** for **localized prostate cancer**, preserving **quality of life while effectively treating the disease**.

This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Read more.
Dr Christos Mikropoulos: Are black men more likely to get prostate cancer
00:27
Playlist
Prostate Cancer
Book your consultation
SUMMARY
Dr. Christos Mikropoulos (Oncologist, The Focal Therapy Clinic): Black men are twice as likely to develop prostate cancer as white men, with 1 in 4 at risk. Family history further increases the risk, making PSA screening and proactive health checks essential for early detection and better outcomes. Dr Christos Mikropoulos - https://www.thefocaltherapyclinic.co.uk/about-us/our-consultants/dr-christos-mikropoulos/ prostate cancer in black males - https://www.thefocaltherapyclinic.co.uk/blog/prostate-cancer-black-males/ Errol McKeller - https://www.thefocaltherapyclinic.co.uk/living-with-prostate-cancer/prostate-cancer-screening-for-black-men-1-in-4/ genetic screening - https://www.thefocaltherapyclinic.co.uk/blog/prostate-cancer-genetic-screening/ Website: https://www.thefocaltherapyclinic.co.uk LinkedIn: linkedin.com/company/the-focal-therapy-clinic/ Facebook: facebook.com/TheFocalTC Telephone: +44 (0) 207 036 8870 #ProstateCancer #MensHealth #CancerScreening #PSATest #EarlyDetection #ProstateHealth

TRANSCRIPT
Dr. Christos Mikropoulos: **Black men are twice as likely to develop prostate cancer** compared to white men. ### **Key Risk Factors:** - **Approximately 1 in 4 Black men** will develop prostate cancer. - **Family history further increases the risk**. - Being **proactive with PSA testing and health monitoring is essential**. Since early detection improves treatment outcomes, **regular PSA screening and medical check-ups are strongly recommended** for those at higher risk.

This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Read more.
Mr Raj Nigam: Do I need treatment for my prostate cancer
01:37
Playlist
Prostate Cancer
Book your consultation
SUMMARY
Mr. Raj Nigam (Consultant Urologist, The Focal Therapy Clinic): The decision to treat prostate cancer depends on risk categorization. Gleason 6 (Grade Group 1) is usually monitored, while Gleason 7 (3+4) or higher typically requires treatment, balancing cancer control with quality of life. Mr Raj Nigam - https://www.thefocaltherapyclinic.co.uk/about-us/our-consultants/mr-raj-nigam/ treatment options - https://www.thefocaltherapyclinic.co.uk/living-with-prostate-cancer/treatment-options/ test for prostate cancer - https://www.thefocaltherapyclinic.co.uk/blog/what-is-the-most-accurate-test-for-prostate-cancer/ stages of prostate cancer - https://www.thefocaltherapyclinic.co.uk/blog/stages-of-prostate-cancer/ 00:00 Introduction: Deciding Whether Prostate Cancer Needs Treatment 00:01 Factors That Determine Treatment Need 00:05 Importance of Cancer Grade and Risk Categorization 00:10 How We Assess Prostate Cancer Risk 00:14 Key Factors: PSA Levels, MRI Findings, and Gleason Grade 00:39 When Is Treatment Recommended? 00:40 Gleason 6 (Grade Group 1 3+3): Low-Risk, Usually Monitored 00:52 Standard Approach in the UK and Europe: Active Surveillance 00:56 Gleason 7 (Grade Group 2 3+4): Intermediate-Risk, Usually Treated 00:59 Ongoing Research: Can Some 3+4 Tumours Be Monitored? 01:00 Gleason 7 (4+3) or Higher: High-Risk, Treatment Strongly Recommended 01:07 Discussing Individual Risk and Options with Your Specialist

TRANSCRIPT
Mr. Raj Nigam: The decision on whether **prostate cancer requires treatment** depends on the **grade of the cancer** and its **risk categorization**. ### **How We Assess Prostate Cancer Risk** We evaluate: 1. **PSA levels** – The blood test done at diagnosis. 2. **Radiological staging** – MRI findings showing cancer location and spread. 3. **Pathological staging** – The **Gleason grade**, which defines how aggressive the cancer is. ### **When Is Treatment Recommended?** - **Gleason 6 (Grade Group 1, 3+3)** → **Low-risk prostate cancer** - Usually **monitored with active surveillance** rather than treated. - This is the standard approach in the **UK and Europe**. - **Gleason 7 (Grade Group 2, 3+4)** → **Intermediate-risk cancer** - Generally **treated**, though research is ongoing to see if **small-volume 3+4 tumors can be monitored**. - **Gleason 7 (4+3) or higher** → **High-risk prostate cancer** - **Treatment is strongly recommended** to prevent progression. The **best approach depends on individual risk factors**, and men diagnosed with prostate cancer should discuss their **options carefully** with their specialist.

This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Read more.
Dr Christos Mikropoulos: How long can I live with prostate cancer?
00:23
Playlist
Prostate Cancer
Book your consultation
SUMMARY
Dr. Christos Mikropoulos (Oncologist, The Focal Therapy Clinic): Life expectancy with prostate cancer depends on the stagelocalized cancer often allows for a normal lifespan, while advanced cases may shorten life expectancy. However, many men live for years even with metastases, thanks to modern treatments and ongoing medical advancements. Dr Christos Mikropoulos - https://www.thefocaltherapyclinic.co.uk/about-us/our-consultants/dr-christos-mikropoulos/ How long can you live with prostate cancer without treatment - https://www.thefocaltherapyclinic.co.uk/blog/how-long-can-you-live-with-prostate-cancer-without-treatment/ living with prostate cancer - https://www.thefocaltherapyclinic.co.uk/living-with-prostate-cancer/

TRANSCRIPT
Dr. Christos Mikropoulos: Life expectancy with **prostate cancer** depends on **the stage at diagnosis**: - **Localized prostate cancer** → Most men have a **normal life expectancy** if treated appropriately. - **Advanced or metastatic prostate cancer** → Life expectancy may be **shortened**, but many men still live **for years** with modern treatments. Even with **metastatic prostate cancer**, we now have **effective treatments** that help **extend life and improve quality of life**.

This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Read more.
Dr Christos Mikropoulos: Is prostate cancer genetic?
N/A
Playlist
Prostate Cancer
Book your consultation
SUMMARY
Dr. Christos Mikropoulos (Oncologist, The Focal Therapy Clinic): Most prostate cancer cases are not genetic, but family history and BRCA mutations can double the risk, especially in younger men and aggressive cases. Understanding genetic factors can help guide screening and early detection strategies. Dr Christos Mikropoulos - https://www.thefocaltherapyclinic.co.uk/about-us/our-consultants/dr-christos-mikropoulos/ genetics and prostate cancer - https://www.thefocaltherapyclinic.co.uk/blog/family-history-of-prostate-cancer/ tests for prostate cancer - https://www.thefocaltherapyclinic.co.uk/blog/what-is-the-most-accurate-test-for-prostate-cancer/ 00:00 Are Most Prostate Cancers Genetic? 00:02 Lifestyle Factors: Obesity & Aging as Major Contributors 00:05 Only a Small Percentage Linked to Genetic Predisposition 00:16 When Genetics Matters More: Younger Men & Aggressive Cancers 00:25 Family History: Risk with a First-Degree Relative 00:28 Diagnosed at a Young Age Doubles Your Risk 00:37 Genes Involved: BRCA Mutations & Their Role in Prostate Cancer

TRANSCRIPT
Dr. Christos Mikropoulos: The **majority of prostate cancer cases are not linked to genetic predisposition**. Instead, they are often associated with: - **Lifestyle factors**, such as obesity. - **The natural aging process**. ### **When Genetics Play a Role** However, **some cases of prostate cancer**—particularly in **younger men or aggressive cases**—can be **genetically linked**. - If you have a **first-degree relative** (father, brother) diagnosed with **prostate cancer at a young age**, your risk is **twice as high** as your peers. - **BRCA gene mutations**, which are known to increase the risk of **breast cancer in women**, can also **predispose men to prostate cancer**. ### **What This Means for You** If you have a **family history of prostate cancer or known genetic mutations**, you may benefit from: - **Earlier PSA testing** and screening. - **Genetic counseling** to assess your risk. - **Lifestyle modifications** to help lower your overall cancer risk. Understanding **your genetic and lifestyle risk factors** can help you make **informed decisions** about screening and prevention.

This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Read more.
Mr Alan Doherty: Is prostate cancer curable?
00:26
Playlist
Prostate Cancer
Book your consultation
SUMMARY
Mr. Alan Doherty (Consultant Urologist, The Focal Therapy Clinic): Prostate cancer is highly curable if it hasnt spread. Cancer is only potentially lethal once it spreads, but it usually takes time to do so, allowing for effective treatment and cure when detected early. Mr Alan Doherty - https://www.thefocaltherapyclinic.co.uk/about-us/our-consultants/mr-alan-doherty/ Success rate - https://www.thefocaltherapyclinic.co.uk/focal-therapy/success-and-clinical-evidence/ focal therapy - https://www.thefocaltherapyclinic.co.uk/focal-therapy/ testing - https://www.thefocaltherapyclinic.co.uk/blog/what-is-the-most-accurate-test-for-prostate-cancer/

TRANSCRIPT
Mr. Alan Doherty: **Prostate cancer is highly curable if it hasn’t spread.** A cancer is only **potentially lethal** once it has learned to **spread beyond the prostate**, and that process **takes time**. If prostate cancer is **detected early and remains localized**, there are **multiple effective treatment options** that can lead to a **complete cure**. Early **detection and intervention** are key to ensuring the **best outcomes** for men with prostate cancer.

This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Read more.
Dr Christos Mikropoulos Can I prevent prostate cancer
00:27
Playlist
Prostate Cancer
Book your consultation
SUMMARY
Dr. Christos Mikropoulos (Oncologist, The Focal Therapy Clinic): A healthy lifestyle may reduce prostate cancer risk, but it cannot be completely prevented. Regular exercise, weight management, and healthy habits can help lower risk and support overall well-being, making proactive health choices essential.

TRANSCRIPT
Dr. Christos Mikropoulos: **Prostate cancer** is one of the most **common cancers in men**. ### **Can You Prevent Prostate Cancer?** While there is **no guaranteed way to prevent it**, you can take steps to **reduce your risk**, including: - **Regular exercise** - **Maintaining a healthy weight** - **Following a balanced diet** These lifestyle changes **may lower your risk**, but they **cannot eliminate the possibility of developing prostate cancer altogether**. Early detection through **regular screening and PSA testing** remains crucial for identifying prostate cancer at a **treatable stage**.

This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Read more.
Dr Christos Mikropoulos What is radiotherapy for prostate cancer
00:37
Playlist
Prostate Cancer
Book your consultation
SUMMARY
Dr. Christos Mikropoulos (Oncologist, The Focal Therapy Clinic): Radiotherapy is a widely used prostate cancer treatment, utilizing precision-shaped photon beams to target cancer while minimizing harm to surrounding tissues. This advanced approach ensures effective cancer control with reduced side effects.

TRANSCRIPT
Dr. Christos Mikropoulos: **Radiotherapy** is a widely used **treatment for prostate cancer**, performed throughout the world. ### **How Radiotherapy Works** - It uses **photon beams** to **precisely target and destroy prostate cancer cells**. - The beams are **carefully shaped** to ensure that they **treat the prostate while minimizing harm to surrounding tissues**. ### **Effectiveness & Side Effects** - **Radiotherapy is highly effective** in treating prostate cancer. - When delivered correctly, it has **fewer side effects** than older radiation techniques, improving patient outcomes. Radiotherapy continues to be a **leading option for prostate cancer treatment**, offering **curative potential while preserving quality of life**.

This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Read more.
Mr Marc Laniado Does focal therapy cure cancer
00:31
Playlist
Prostate Cancer
Book your consultation
SUMMARY
Mr. Marc Laniado (Consultant Urologist, The Focal Therapy Clinic): Focal therapy is highly effectivefor every five men treated, four will not require further major treatment. Only one in five may eventually need surgery or radiotherapy, making focal therapy a minimally invasive and long-term option for prostate cancer management.

TRANSCRIPT
Mr. Marc Laniado: When you undergo **focal therapy**, we know that the treatment is **highly effective**. For every **five men treated**: - **Four will never need further major treatment** beyond focal therapy. - **One may require radical prostatectomy or radiotherapy** at some point. For the **vast majority of men**, **focal therapy successfully eliminates the disease**, allowing them to **live the rest of their lives** without needing more aggressive treatment.

This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Read more.
Mr Alan Doherty Should you have your PSA measured
01:09
Playlist
Prostate Cancer
Book your consultation
SUMMARY
Mr. Alan Doherty (Consultant Urologist, The Focal Therapy Clinic): PSA testing provides useful information, but anxiety over high results is common. A high-quality MRI can help clarify risks, and monitoring PSA over time ensures a more accurate assessment before deciding on further tests or treatment.

TRANSCRIPT
Mr. Alan Doherty: Should you have your **PSA measured?** I believe there is **no harm in getting more information**—what matters is **how you handle that information**. Some people experience **significant anxiety** over a **high PSA result**. In fact, PSA has been jokingly referred to as **Promoting Stress and Anxiety** because of the worry it causes. However, patients should find reassurance in **high-quality MRI scans**. If an MRI does **not detect any abnormalities**, and there is a clear reason for a **borderline elevated PSA** (such as a naturally **large prostate**), there is **no immediate cause for concern**. Instead of panicking, the best approach is: - **Monitor PSA levels over time**—if it remains stable, there’s no need to worry. - **If PSA continues to rise**, further diagnostic tests may be needed. In summary, **PSA testing itself is not harmful**, but **how you react to the results** is what can be stressful. With **expert interpretation and proper follow-up**, PSA testing can be a **valuable tool** in **prostate cancer detection and monitoring**.

This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Read more.
Dr Christos Mikropoulos Is a PSA test reliable
00:24
Playlist
Prostate Cancer
Book your consultation
SUMMARY
Dr. Christos Mikropoulos (Oncologist, The Focal Therapy Clinic): PSA tests are highly sensitive and specific, but not perfect. Their accuracy improves when interpreted by specialists who understand their limitations and context, ensuring the most reliable diagnosis and appropriate next steps.

TRANSCRIPT
Dr. Christos Mikropoulos: **PSA tests** are a **reliable tool** for detecting prostate cancer, but they are **not perfect**. Like any **biomarker**, PSA testing is never **100% accurate**, but it does have **high sensitivity and specificity**. The key to using PSA tests effectively is **expert interpretation**. When assessed by **specialists**, PSA results can be **better understood** in the context of an individual's overall health, helping to **avoid unnecessary worry** or **misdiagnosis**.

This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Read more.
Dr Christos Mikropoulos What is watchful waiting
00:29
Playlist
Prostate Cancer
Book your consultation
SUMMARY
Dr. Christos Mikropoulos (Oncologist, The Focal Therapy Clinic): Watchful waiting is used when prostate cancer cannot be cured, focusing on symptom management rather than aggressive treatment. This approach helps avoid unnecessary side effects while maintaining the best possible quality of life for patients.

TRANSCRIPT
Dr. Christos Mikropoulos: If you have been placed on **watchful waiting**, it means that **your clinician has determined this is the best approach** for managing your prostate cancer at this stage. At this point, your **prostate cancer is not curable**, but we can: - **Manage symptoms** as they arise. - **Maintain a good quality of life** without exposing you to the **side effects of aggressive treatments**. Watchful waiting allows us to **focus on symptom control** rather than attempting curative treatment, ensuring that your well-being remains the priority.

This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Read more.
Dr Christos Mikropoulos Is chemotherapy used for prostate cancer
00:20
Playlist
Prostate Cancer
Book your consultation
SUMMARY
Dr. Christos Mikropoulos (Oncologist, The Focal Therapy Clinic): Chemotherapy is used for advanced or metastatic prostate cancer, not for localized cases. Patients eligible for focal therapy do not require chemotherapy, as their treatment targets the cancer while preserving healthy tissue and function.

TRANSCRIPT
Dr. Christos Mikropoulos: **Chemotherapy** is used in **prostate cancer**, but only for **metastatic or advanced cases**. Patients who are eligible for **focal therapy** have **localized prostate cancer** and **do not require chemotherapy** as part of their treatment plan.

This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Read more.
Mr Raj Nigam Why have I been put on watchful waiting
01:14
Playlist
Prostate Cancer
Book your consultation
SUMMARY
Mr. Raj Nigam (Consultant Urologist, The Focal Therapy Clinic): Watchful waiting is typically recommended for men over 80, while active surveillance applies to younger patients with low-risk prostate cancer. However, fit older men can still benefit from focal therapy if they are suitable candidates, offering a minimally invasive treatment option.

TRANSCRIPT
Mr Raj Nigam: We now primarily use the term watchful waiting for men over the age of 80. Traditionally, this term applied to men who would never be considered for radical treatment options. For younger men who may still be candidates for radical or focal therapy, we use the term active surveillance. Watchful waiting is reserved for older men who would typically not be offered radical treatment. However, this does not mean they are excluded from focal therapy. I have treated many fit and active men in their 80s who wanted to preserve their quality of life and were only offered watchful waiting. If they are suitable, focal therapy—a minimally invasive treatment that can be repeated if necessary—is an excellent option for these individuals.

This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Read more.
Brachytherapy for prostate cancer
00:24
Playlist
Prostate Cancer
Book your consultation
SUMMARY
Dr. Christos Mikropoulos (Oncologist, The Focal Therapy Clinic): Brachytherapy is internal radiotherapy, using radioactive seeds implanted in the prostate to deliver targeted treatment while minimizing damage to surrounding tissues. This precise approach helps reduce side effects compared to external beam radiotherapy.

TRANSCRIPT
Dr. Christos Mikropoulos: ### **What Is Brachytherapy?** Brachytherapy is a **form of radiotherapy that is delivered up close**—hence the name, as brachy in Greek means **close**. This treatment is also known as **internal radiotherapy**, as it involves placing **radioactive seeds or small pellets directly into the prostate**. ### **How Does It Work?** - **Radioactive seeds** are implanted into the prostate gland. - These seeds **deliver radiation directly to the cancer**, minimizing exposure to **surrounding healthy tissue**. - This **targeted approach** helps reduce **side effects compared to external beam radiotherapy**. ### **Key Benefits of Brachytherapy** - **Highly precise treatment**. - **Minimally invasive** compared to surgery. - **Reduced radiation exposure to surrounding organs** like the bladder and rectum. Brachytherapy is a **well-established and effective option** for treating localized prostate cancer, especially in men looking for a **less invasive alternative to surgery**.

This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Read more.
Is focal therapy effective against prostate cancer?
01:07
Playlist
Prostate Cancer
Book your consultation
SUMMARY
Mr. Raj Nigam (Consultant Urologist) & Dr. Christos Mikropoulos (Consultant Oncologist) The Focal Therapy Clinic: Focal therapy is as effective as radical prostatectomy at 8 years, with lower incontinence rates (less than 2%) and most men remaining disease-free while avoiding radical treatment. This minimally invasive approach offers excellent cancer control while preserving quality of life.

TRANSCRIPT
Mr. Raj Nigam & Dr. Christos Mikropoulos: ### **Focal Therapy vs. Radical Prostatectomy: Long-Term Outcomes** Observational studies have monitored men **for many years** after treatment. - At **8 years**, there is **no oncological difference** in outcomes between **focal therapy and radical prostatectomy**. - This confirms that **focal therapy is highly effective** in treating prostate cancer while minimizing side effects. ### **Focal Therapy’s Success & Side Effect Profile** - **Focal therapy effectively destroys cancer cells**, as confirmed by long-term research. - The risk of **incontinence is less than 1–2%**, compared to **10% or more with radical surgery**. - Most men treated with **focal therapy remain disease-free** and **avoid needing surgery or radiotherapy**. ### **Key Takeaway** We have strong **scientific evidence** that **focal therapy works**, offering men a **safe, effective, and minimally invasive alternative to radical treatment**.

This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Read more.
Do more black men get prostate cancer?
00:27
Playlist
Prostate Cancer
Book your consultation
SUMMARY
Dr. Christos Mikropoulos (Oncologist, The Focal Therapy Clinic): Black men are twice as likely to develop prostate cancer as white men, with 1 in 4 at risk. A family history further increases the risk, making PSA screening and proactive health checks essential for early detection and better treatment outcomes.

TRANSCRIPT
Dr. Christos Mikropoulos: ### **Prostate Cancer Risk in Black Men** **Black men are twice as likely to develop prostate cancer** compared to white men. - **Approximately 1 in 4 Black men** will develop prostate cancer. - **A family history further increases the risk**. ### **Why Proactive Screening Matters** - Regular **PSA testing and health monitoring** can lead to **early detection**, which improves treatment outcomes. - Black men should be particularly **proactive about prostate health**, given their **higher genetic predisposition**. ### **Key Takeaway** If you are at **higher risk due to race or family history**, **regular PSA checks and medical screenings are crucial** for early intervention and better outcomes.

This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Read more.
What is the prostate and what does it do?
00:28
Playlist
Prostate Cancer
Book your consultation
SUMMARY
Mr. Marc Laniado (Consultant Urologist, The Focal Therapy Clinic): The prostate gland surrounds the urethra, is about the size of a walnut, and plays a vital role in reproductive health. It produces semen to nourish sperm and aid fertilization, while also playing a key role in ejaculation during orgasm.

TRANSCRIPT
Mr. Marc Laniado: Okay, the **prostate gland** surrounds the **urethra**, just **below the bladder** and **in front of the rectum**. - It is **about the size of a walnut** in most men. - Its primary function is to **produce semen**, which **nourishes sperm** and helps with **fertilization**. - The prostate also **assists in ejaculation**, helping propel semen during **orgasm**. While the prostate is **important for reproductive health**, it is **not essential for urinary function or hormone production**, which is why treatments like **focal therapy** can target the gland while preserving key functions.

This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Read more.
Can young men get prostate cancer?
00:35
Playlist
Prostate Cancer
Book your consultation
SUMMARY
Mr. Alan Doherty (Consultant Urologist, The Focal Therapy Clinic): Prostate cancer is rare under 40 but can occur in all men over that age. Since it often develops slowly, age is an important factor in treatment decisions. Understanding risk factors and screening options ensures early detection and better outcomes.

TRANSCRIPT
Mr. Alan Doherty: Prostate cancer is **seen in all age groups over 40**, but it is **very rare in men younger than 40**. ### **Why Age Matters in Prostate Cancer** - **Prostate cancer is most common in older men**. - **It often develops slowly**, so age is **a key factor in deciding when and how to treat it**. - Some cancers **remain slow-growing for years**, meaning that treatment decisions must consider **both the patient’s age and life expectancy**. Understanding how **age influences prostate cancer progression** helps guide **treatment choices**, balancing **cancer control with quality of life**.

This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Read more.
Why you need a prostate cancer second opinion
01:12
Playlist
Prostate Cancer
Book your consultation
SUMMARY
Mr. Raj Nigam (Consultant Urologist, The Focal Therapy Clinic): Getting a second opinion helps explore all treatment options, not just surgery or radiotherapy. Our multidisciplinary team (MDT) includes top specialists who ensure patients receive the best, most personalized advice tailored to their diagnosis and priorities.

TRANSCRIPT
Mr. Raj Nigam: ### **Why Getting a Second Opinion Matters** When you've just been diagnosed with **prostate cancer**, it can be **incredibly helpful to seek a second opinion**. - Many **clinicians have their own perspective** on treatment, often focused on **surgery or radiotherapy**. - A second opinion allows you to **explore different approaches** and consider **all available options**. ### **Expert Multidisciplinary Team (MDT) Review** At **The Focal Therapy Clinic**, we have a team that includes: - **A leading urological radiologist** - **A top urological oncologist** This allows us to **discuss your case thoroughly** in our **MDT meeting** and provide you with a **refined, expert-led recommendation**. ### **Expanding Treatment Options** - Many urologists **specialize in surgery or radiotherapy** and may not be familiar with **all available treatments**. - Some **diagnostic tests and treatment options** might not even be discussed. - Seeing a **focal therapy expert** ensures that you are **considered for the full range of treatments**, rather than just the **traditional options**. ### **Key Takeaway** A **second opinion gives you confidence** that you're making the **best treatment decision** based on **all available options**, including **minimally invasive focal therapy**.

This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Read more.

Active surveillance and watchful waiting

If your cancer is diagnosed early or is very slow growing, your doctor might decide it doesn’t need treatment straight away. Instead, you will have regular PSA tests and MRI scans to monitor how your cancer is developing. If any changes are detected, you may need a biopsy to confirm them (transperineal or transrectal). An active surveillance or watchful waiting approach has been championed because it can reduce ‘unnecessary’ radical treatments that can lead to major side effects. However, many people find that knowing they have cancer causes severe anxiety.

How is prostate cancer diagnosed?

PSA tests

PSA, or prostate-specific antigen, is a protein produced by your prostate gland. Everyone with a normal prostate will have a small amount of PSA in their bloodstream, but elevated levels can indicate prostate problems, including cancer. To check your PSA level, your doctor will take a small blood sample and send it to a lab to be measured.

Regular PSA tests will show any increases from your normal level and show more accurately if there could be a problem. If your PSA is found to be increasingly rapidly, or is over 4, you are likely to be referred for an MRI to investigate further. If you are on active surveillance, you may have PSA tests every 3-6 months.

MRI scans

You should have had a magnetic resonance image (MRI) scan when you were first diagnosed to look for any abnormalities in your prostate, if your PSA was found to be rising. If any cancer is found on your MRI, it will be used to guide your biopsy and diagnose your cancer more reliably. An MRI scan uses magnetism and radio waves to make a picture of the inside of your body.

mpMRI

A multiparametric MRI, also called a prostate MRI, combines 4 different images to make a very high-quality image of your prostate cancer. This provides your specialist even more information than a normal MRI. Approximately 80% of hospitals in UK now have access to mpMRI scans for enhanced imaging and target biopsies. However, not all hospitals are offering a full mpMRI; many offer a biparametric scan, which is less definitive. Learn more about MRIs for prostate cancer.

Biopsies

Finding cancerous tissue via a biopsy is needed to definitively diagnose prostate cancer. All biopsies used to be conducted transrectally; this means a thin needle is used to collect tissue samples through the rectum. It’s usually done under local anaesthetic, so you are awake during the procedure. Many people find transrectal biopsies painful and there is a strong risk of infection.

Now, NICE recommends that transperineal biopsies are used to diagnose and monitor prostate cancer. The needle enters through the skin between the scrotum and rectum. Compared with transrectal biopsies, they are as accurate but have a much lower risk of infection and sepsis.

NHS hospitals will often perform biopsies under local anaesthetic, which can be painful. If you have a biopsy done privately, you will have the option for it to be done under general anaesthetic, which allows for significantly improved accuracy and enhanced patient comfort.

Fusion biopsies are another way that biopsies have been made less painful, safer and more useful. Your MRI scan is combined with a real-time ultrasound so only the suspicious areas are biopsied.

Any questions?

If you’ve got any questions about your prostate cancer diagnosis or want to know more about HIFU or NanoKnife, don’t hesitate to get in touch with our friendly, knowledgeable team.

0207 036 8870

info@thefocaltherapyclinic.co.uk

Contact the team






    Learn more about living with prostate cancer

    Frequently asked questions

    Which prostate cancer treatment has the fewest side effects?
    Focal therapy has the lowest side effect rates among active treatments, with incontinence affecting less than 2% of patients compared to 5–20% after surgery, and erectile function preserved in over 90% versus 30–70% after radical prostatectomy. Among whole-gland treatments, surgery carries higher immediate risks to continence and erections, while radiotherapy causes bowel side effects in up to 20% of patients and gradual functional decline over years.
    When is focal therapy preferred over radiotherapy or prostatectomy?
    Focal therapy is ideal for localised, low-to-intermediate risk disease (Gleason 6–7, PSA ≤20 ng/mL) clearly visible on multiparametric MRI, where preservation of sexual and urinary function is a priority. It suits patients with life expectancy over 10 years who value maintaining future treatment options. Surgery may be preferred for higher-grade disease in younger patients, while radiotherapy suits those unable to undergo surgery or requiring combination with hormone therapy.
    Can I have other treatments after focal therapy if needed?
    Yes, focal therapy preserves all future treatment options. If cancer recurs, you can undergo repeat focal therapy, radiotherapy, or surgery with outcomes comparable to primary treatment. In contrast, surgery eliminates most future local treatment options, and radiotherapy limits subsequent surgical feasibility. This treatment flexibility represents modern cancer management—starting with the least invasive option while keeping more aggressive treatments available if needed.
    How do I decide between HIFU and NanoKnife focal therapy?
    HIFU uses focused ultrasound heat to destroy cancer cells and is ideal for posterior (lower/back) tumours away from the rectum. NanoKnife uses electrical pulses without heat and excels for anterior (front/upper) tumours near the urethra where thermal ablation carries higher risks. Both are NICE-approved with equivalent cancer control and functional preservation. Your consultant recommends the optimal technology based on your specific tumour location identified on MRI.
    What are the recovery times for different prostate cancer treatments?
    Focal therapy allows return to normal activities within 3–5 days, with catheter removal typically in 1–5 days and sexual activity resuming after 2–4 weeks. Radical prostatectomy requires 6–12 weeks full recovery, with hospital stay of 3–7 days and catheter for 10–14 days. Radiotherapy involves 6–8 weeks of daily hospital visits with cumulative fatigue. Active surveillance requires no recovery but involves ongoing monitoring appointments.
    Which treatment best preserves sexual function?
    Focal therapy preserves sexual function best, with over 90% of men maintaining erectile function by targeting only the cancerous area and avoiding damage to neurovascular bundles responsible for erections. Nerve-sparing prostatectomy achieves 30–70% preservation (highly surgeon-dependent), while radiotherapy preserves function in 40–70% initially but causes progressive vascular damage over years. For men under 70 with good baseline function who prioritise sexual health, focal therapy offers the highest probability of maintaining natural erections.
    Who is a good candidate for each treatment type?
    Active surveillance suits very low-risk disease (Gleason 6, PSA <10 ng/mL). Focal therapy is ideal for localised, low-to-intermediate risk disease (Gleason 6–7, PSA ≤20 ng/mL) visible on MRI where quality of life preservation is paramount. Surgery may be recommended for higher-risk disease (Gleason 8+) in younger men who accept higher side effect risks. Radiotherapy suits those unable to undergo surgery or with higher-risk disease requiring hormone therapy combination. Approximately 50–60% of newly diagnosed patients are focal therapy candidates.
    Is focal therapy as effective as surgery for cancer control?
    For appropriately selected patients with localised disease, focal therapy demonstrates equivalent cancer control to radical treatments. Studies show 90% of clinically significant cancer eliminated at 1 year, with 75–80% of men avoiding radical treatment for 6–10 years. The 12% who experience recurrence can undergo repeat focal therapy or progress to surgery/radiotherapy with outcomes comparable to primary treatment. Long-term randomised trials comparing focal therapy to prostatectomy are underway, but current data supports focal therapy as a definitive treatment for MRI-visible, intermediate-risk disease.

    Book your consultation

    Subscribe to our newsletter

    Get expert advice & the latest prostate cancer research - straight to your inbox.

      We care about your data in our privacy policy.

      Page Metadata

      Page Type: Educational Hub Page with Video Library

      Page URL: https://www.thefocaltherapyclinic.co.uk/living-with-prostate-cancer/

      Main Topic: Living with Prostate Cancer - Patient Education and Treatment Decision Support

      Medical Condition: Prostate Cancer (Prostatic Carcinoma)

      ICD-10 Code: C61 (Prostate Cancer)

      Medical Specialty: Urology (https://www.wikidata.org/wiki/Q177005)

      Date Published: 2024-02-27T11:36:24+00:00

      Date Modified: 2025-10-22T09:24:37+00:00

      Language: en-GB

      Page Title: Living with Prostate Cancer

      Page Description: Living with prostate cancer and want to understand your PSA, MRI or biopsy results and the range of treatment options available? Get in touch

      Extended Description: Comprehensive educational hub covering prostate cancer diagnosis, treatment options, side effect comparisons, and patient decision support. Features 28 educational videos, 8 FAQs, and expert guidance from consultant urologists and oncologists.

      Estimated Reading Time: 7 minutes

      Content Format: Educational hub, Video library (28 videos), FAQ (8 questions), Treatment comparisons, Diagnostic information

      Content Freshness: Last modified October 22, 2025 (excellent - within 1 month)

      Breadcrumb Navigation

      Level 1: Home - https://www.thefocaltherapyclinic.co.uk/

      Level 2: Living with prostate cancer (Current Page)

      Organization Information

      Organization Name: The Focal Therapy Clinic

      Organization Type: Medical Organization

      Medical Specialty: Urology (https://www.wikidata.org/wiki/Q177005)

      Organization URL: https://www.thefocaltherapyclinic.co.uk/

      Logo URL: https://www.thefocaltherapyclinic.co.uk/wp-content/uploads/2024/10/cropped-TFTC_logo_square_512x512.png

      Logo Dimensions: 512x512 pixels

      Logo Caption: The Focal Therapy Clinic

      Social Media - Facebook: https://www.facebook.com/THeFocalTC

      Social Media - X (Twitter): https://x.com/thefocaltc

      Website Search: https://www.thefocaltherapyclinic.co.uk/?s={search_term_string}

      Medical Condition - Prostate Cancer

      Condition Name: Prostate Cancer

      Alternate Name: Localised Prostate Cancer, Prostatic Carcinoma

      ICD-10 Code: C61

      Coding System: ICD-10 (International Classification of Diseases, 10th Revision)

      Wikidata Reference: https://www.wikidata.org/wiki/Q181257

      Condition URL: https://www.thefocaltherapyclinic.co.uk/prostate-cancer/

      Risk Factors: Age (rare under 40, increases with age), family history, ethnicity (higher risk in Black men), PSA levels

      Diagnosis Methods: PSA blood test, Digital Rectal Exam (DRE), Multiparametric MRI, Transrectal biopsy, Transperineal biopsy, Fusion biopsy

      Grading System: Gleason score (Grade Groups 1-5), PSA levels, MRI staging

      Medical Professionals Featured (E-E-A-T Authority)

      Total Professionals: 4 medical specialists

      Professional Types: 3 Consultant Urologists + 1 Consultant Oncologist

      All registered with General Medical Council (GMC)

      Consultant 1: Mr Raj Nigam

      GMC Number: 4655049

      Full Name: Mr Raj Nigam

      Job Title: Consultant Urologist

      Professional Fellowship: Fellow of the Royal College of Surgeons (FRCS)

      Recognized By: Royal College of Surgeons

      Profile URL: https://www.thefocaltherapyclinic.co.uk/about-us/our-consultants/mr-raj-nigam/#person

      LinkedIn: https://www.linkedin.com/in/raj-nigam-consultant-urologist

      BAUS Surgical Outcomes: https://www.baus.org.uk/patients/surgical-outcomes/consultant/4655049

      Areas of Medical Expertise

      • Focal therapy
      • HIFU (High-Intensity Focused Ultrasound)
      • NanoKnife (Irreversible Electroporation)
      • Prostate cancer
      • Treatment decision-making
      • Active surveillance

      Role on Page: Medical reviewer and video contributor

      Consultant 2: Mr Marc Laniado

      GMC Number: 4729534

      Full Name: Mr Marc Laniado

      Job Title: Consultant Urologist

      Professional Fellowship: Fellow of the Royal College of Surgeons (FRCS)

      Recognized By: Royal College of Surgeons

      Profile URL: https://www.thefocaltherapyclinic.co.uk/about-us/our-consultants/mr-marc-laniado/#person

      LinkedIn: https://www.linkedin.com/in/marc-laniado-urologist

      BAUS Surgical Outcomes: https://www.baus.org.uk/patients/surgical-outcomes/consultant/4729534

      Areas of Medical Expertise

      • Focal therapy
      • HIFU treatment
      • NanoKnife treatment
      • Prostate cancer
      • MRI fusion biopsy
      • Treatment outcomes

      Role on Page: Medical reviewer and video contributor

      Consultant 3: Mr Alan Doherty

      Full Name: Mr Alan Doherty

      Job Title: Consultant Urologist

      Professional Fellowship: Fellow of the Royal College of Surgeons

      Profile URL: https://www.thefocaltherapyclinic.co.uk/about-us/our-consultants/mr-alan-doherty/#person

      Areas of Medical Expertise

      • Prostate cancer diagnosis and treatment
      • Focal therapy procedures
      • Patient education
      • Age and risk stratification

      Role on Page: Video contributor - patient education content

      Consultant 4: Dr Christos Mikropoulos

      Full Name: Dr Christos Mikropoulos

      Job Title: Consultant Oncologist

      Medical Specialty: Oncology (Cancer Treatment)

      Profile URL: https://www.thefocaltherapyclinic.co.uk/about-us/our-consultants/dr-christos-mikropoulos/#person

      Areas of Medical Expertise

      • Prostate cancer oncology
      • Radiotherapy for prostate cancer
      • Brachytherapy
      • Advanced prostate cancer management
      • Cancer prognosis assessment

      Role on Page: Video contributor - oncology perspective

      Medical Procedures Featured

      Total Procedures Documented: 2 NICE-approved focal therapy technologies

      Procedure 1: HIFU (High-Intensity Focused Ultrasound)

      Procedure ID: https://www.thefocaltherapyclinic.co.uk/living-with-prostate-cancer/treatment-options/#proc-hifu

      Procedure Name: High-intensity focused ultrasound (HIFU)

      Alternate Name: HIFU focal therapy

      Procedure Type: Minimally Invasive Procedure

      Body Location: Prostate

      Description: Non-invasive focal therapy using focused ultrasound to heat and destroy cancer cells in the prostate. Ideal for posterior tumours.

      Regulatory Approval

      NICE Code: IPG118

      Coding System: NICE Interventional Procedure Guidance

      Full Name: High-intensity focused ultrasound for prostate cancer

      Reference URL: https://www.nice.org.uk/guidance/ipg118

      Clinical Outcomes

      Continence Preservation: 98-100%

      Continence Description: Urinary incontinence affects less than 2% of patients

      Erectile Function Preservation: 90%+

      Erectile Function Description: Over 90% maintain erectile function post-treatment

      External References

      Wikipedia: https://en.wikipedia.org/wiki/High-intensity_focused_ultrasound

      Validation Source: NICE, BAUS, clinical studies

      Procedure 2: NanoKnife (Irreversible Electroporation)

      Procedure ID: https://www.thefocaltherapyclinic.co.uk/living-with-prostate-cancer/treatment-options/#proc-nanoknife

      Procedure Name: NanoKnife (Irreversible Electroporation)

      Alternate Names: IRE, Irreversible electroporation

      Procedure Type: Minimally Invasive Procedure

      Body Location: Prostate

      Description: Minimally invasive focal therapy using electrical pulses to disrupt cancer cell membranes. Ideal for anterior tumours near critical structures.

      Regulatory Approval

      NICE Code: IPG424

      Coding System: NICE Interventional Procedure Guidance

      Full Name: Irreversible electroporation for treating prostate cancer

      Reference URL: https://www.nice.org.uk/guidance/ipg424

      Clinical Outcomes

      Continence Preservation: 98-100%

      Continence Description: Minimal impact on urinary control

      Erectile Function Preservation: 90%+

      Erectile Function Description: No thermal damage to neurovascular bundles

      External References

      Wikipedia: https://en.wikipedia.org/wiki/Irreversible_electroporation

      Validation Source: NICE, clinical studies, international guidelines

      Treatment Options Overview (Complete Comparison)

      This page provides comprehensive information on all prostate cancer treatment options

      Focal Therapy (HIFU and NanoKnife)

      Treatment Type: Minimally invasive targeted ablation

      Cancer Control: 90% clinically significant cancer eliminated at 1 year, 75-80% avoid radical treatment for 6-10 years

      Erectile Function: 90%+ preservation

      Continence: 98-100% preservation

      Recovery: 3-5 days to normal activities

      Side Effects: Minimal (less than 2% incontinence)

      Future Options: All treatment options remain available

      Ideal For: Localized, low-to-intermediate risk disease (Gleason 6-7, PSA ≤20 ng/mL)

      Candidacy Rate: 50-60% of newly diagnosed patients

      Radical Prostatectomy (Surgery)

      Treatment Type: Surgical removal of entire prostate gland

      Cancer Control: High for localized disease

      Erectile Function: 30-70% preservation (highly surgeon-dependent)

      Continence: 5-20% experience incontinence

      Recovery: 6-12 weeks

      Side Effects: Higher immediate risks to continence and erections

      Future Options: Limited (prostate removed)

      Ideal For: Higher-risk disease (Gleason 8+) in younger men

      Hospital Stay: 3-7 days, catheter 10-14 days

      Radiotherapy (External Beam and Brachytherapy)

      Treatment Type: Radiation targeting prostate

      Cancer Control: High for localized disease

      Erectile Function: 40-70% initially, progressive vascular damage over years

      Continence: Generally preserved

      Recovery: 6-8 weeks of daily hospital visits

      Side Effects: Bowel effects in up to 20%, cumulative fatigue, progressive functional decline

      Future Options: Surgery difficult after radiation

      Ideal For: Unable to undergo surgery or requiring hormone therapy combination

      Active Surveillance

      Treatment Type: Monitoring without immediate treatment

      Cancer Control: N/A (monitoring only)

      Side Effects: None from surveillance itself

      Ideal For: Very low-risk disease (Gleason 6, PSA <10 ng/mL)

      Monitoring: Regular PSA tests, MRI scans, repeat biopsies

      Psychological Impact: Ongoing anxiety for some patients

      Hormone Therapy

      Treatment Type: Androgen deprivation therapy

      Cancer Control: Controls cancer growth, not curative as monotherapy

      Side Effects: Hot flashes, fatigue, loss of libido, erectile dysfunction, muscle loss, bone density loss

      Ideal For: Advanced disease, combination with radiotherapy, recurrence management

      Watchful Waiting

      Treatment Type: Palliative approach for elderly/comorbid patients

      Cancer Control: N/A (symptom management only)

      Ideal For: Life expectancy <10 years, significant comorbidities

      Treatment Comparison Tables

      Table 1: Side Effect Comparison

      Side Effect Focal Therapy Radical Prostatectomy Radiotherapy
      Incontinence Rate Less than 2% 5-20% Low (generally preserved)
      Erectile Function Preservation Over 90% 30-70% (nerve-sparing) 40-70% initially, gradual decline
      Bowel Side Effects Minimal Rare Up to 20% (rectal inflammation, urgency, bleeding)

      Table 2: Recovery Time Comparison

      Treatment Return to Normal Activities Catheter Duration Sexual Activity Resumption
      Focal Therapy 3-5 days 1-5 days 2-4 weeks
      Radical Prostatectomy 6-12 weeks 10-14 days 6-12 weeks
      Radiotherapy 6-8 weeks (daily treatments) N/A Variable, gradual decline over time

      Table 3: Candidacy Criteria

      Treatment Ideal Gleason Score Typical PSA Range Disease Extent
      Active Surveillance Gleason 6 PSA <10 ng/mL Very low-risk, localized
      Focal Therapy Gleason 6-7 (Grade Groups 1-3) PSA ≤20 ng/mL Localized, MRI-visible
      Surgery Gleason 8+ acceptable Variable Higher-risk localized disease
      Radiotherapy Any Gleason score Variable Unable to undergo surgery or requiring hormone therapy

      Frequently Asked Questions (8 Comprehensive Treatment FAQs)

      Complete FAQ schema covering treatment decision-making and comparison

      FAQ 1: Which prostate cancer treatment has the fewest side effects?

      Answer: Focal therapy has the lowest side effect rates among active treatments, with incontinence affecting less than 2% of patients compared to 5-20% after surgery, and erectile function preserved in over 90% versus 30-70% after radical prostatectomy. Among whole-gland treatments, surgery carries higher immediate risks to continence and erections, while radiotherapy causes bowel side effects in up to 20% of patients and gradual functional decline over years.

      Key Points

      • Focal therapy: <2% incontinence, 90%+ erectile function preservation
      • Surgery: 5-20% incontinence, 30-70% erectile function preservation
      • Radiotherapy: Bowel effects in up to 20%, gradual functional decline
      • Focal therapy preserves healthy tissue and critical structures

      FAQ 2: When is focal therapy preferred over radiotherapy or prostatectomy?

      Answer: Focal therapy is ideal for localized, low-to-intermediate risk disease (Gleason 6-7, PSA ≤20 ng/mL) clearly visible on multiparametric MRI, where preservation of sexual and urinary function is a priority. It suits patients with life expectancy over 10 years who value maintaining future treatment options. Surgery may be preferred for higher-grade disease in younger patients, while radiotherapy suits those unable to undergo surgery or requiring combination with hormone therapy.

      Focal Therapy Ideal Criteria

      • Gleason 6-7 (Grade Groups 1-3)
      • PSA ≤20 ng/mL
      • MRI-visible localized disease
      • Life expectancy >10 years
      • Quality of life preservation priority
      • 50-60% of newly diagnosed patients eligible

      FAQ 3: Can I have other treatments after focal therapy if needed?

      Answer: Yes, focal therapy preserves all future treatment options. If cancer recurs, you can undergo repeat focal therapy, radiotherapy, or surgery with outcomes comparable to primary treatment. In contrast, surgery eliminates most future local treatment options, and radiotherapy limits subsequent surgical feasibility. This treatment flexibility represents modern cancer management—starting with the least invasive option while keeping more aggressive treatments available if needed.

      Future Treatment Options After Focal Therapy

      • Repeat focal therapy (5-10% undergo second ablation)
      • Radiotherapy (all options available)
      • Surgery (prostate intact, outcomes comparable)
      • Hormone therapy
      • Combination approaches
      • Treatment ladder philosophy: start least invasive

      FAQ 4: How do I decide between HIFU and NanoKnife focal therapy?

      Answer: HIFU uses focused ultrasound heat to destroy cancer cells and is ideal for posterior (lower/back) tumours away from the rectum. NanoKnife uses electrical pulses without heat and excels for anterior (front/upper) tumours near the urethra where thermal ablation carries higher risks. Both are NICE-approved with equivalent cancer control and functional preservation. Your consultant recommends the optimal technology based on your specific tumour location identified on MRI.

      Technology Selection Criteria

      • HIFU: Posterior tumours, thermal ablation, ultrasound-based
      • NanoKnife: Anterior tumours, non-thermal, electrical pulse-based
      • Both: NICE-approved, equivalent outcomes
      • Selection: Based on MRI tumour location and size
      • Consultant recommendation: Personalized to your specific case

      FAQ 5: What are the recovery times for different prostate cancer treatments?

      Answer: Focal therapy allows return to normal activities within 3-5 days, with catheter removal typically in 1-5 days and sexual activity resuming after 2-4 weeks. Radical prostatectomy requires 6-12 weeks full recovery, with hospital stay of 3-7 days and catheter for 10-14 days. Radiotherapy involves 6-8 weeks of daily hospital visits with cumulative fatigue. Active surveillance requires no recovery but involves ongoing monitoring appointments.

      Detailed Recovery Timeline - Focal Therapy

      • Days 1-2: Rest at home, mild discomfort, standard painkillers
      • Days 3-5: Return to light activities and office work
      • Weeks 2-4: Resume exercise and sexual activity
      • Weeks 4-6: Full return to strenuous exercise
      • Catheter: 1-5 days typical
      • No surgical incisions (minimally invasive)

      FAQ 6: Which treatment best preserves sexual function?

      Answer: Focal therapy preserves sexual function best, with over 90% of men maintaining erectile function by targeting only the cancerous area and avoiding damage to neurovascular bundles responsible for erections. Nerve-sparing prostatectomy achieves 30-70% preservation (highly surgeon-dependent), while radiotherapy preserves function in 40-70% initially but causes progressive vascular damage over years. For men under 70 with good baseline function who prioritize sexual health, focal therapy offers the highest probability of maintaining natural erections.

      Sexual Function Outcomes

      • Focal Therapy: Over 90% maintain function
      • Nerve-Sparing Surgery: 30-70% (surgeon-dependent)
      • Radiotherapy: 40-70% initially, progressive decline over years
      • Neurovascular bundle preservation crucial for erections
      • Focal therapy avoids damage to nerve bundles
      • Best option for men <70 prioritizing sexual health

      FAQ 7: Who is a good candidate for each treatment type?

      Answer: Active surveillance suits very low-risk disease (Gleason 6, PSA <10 ng/mL). Focal therapy is ideal for localized, low-to-intermediate risk disease (Gleason 6-7, PSA ≤20 ng/mL) visible on MRI where quality of life preservation is paramount. Surgery may be recommended for higher-risk disease (Gleason 8+) in younger men who accept higher side effect risks. Radiotherapy suits those unable to undergo surgery or with higher-risk disease requiring hormone therapy combination. Approximately 50-60% of newly diagnosed patients are focal therapy candidates.

      Candidacy Breakdown

      • Active Surveillance: Gleason 6, PSA <10, very low-risk
      • Focal Therapy: Gleason 6-7, PSA ≤20, localized, MRI-visible (50-60% of patients)
      • Surgery: Gleason 8+, higher-risk, younger patients
      • Radiotherapy: Surgery contraindicated, hormone therapy needed

      FAQ 8: Is focal therapy as effective as surgery for cancer control?

      Answer: For appropriately selected patients with localized disease, focal therapy demonstrates equivalent cancer control to radical treatments. Studies show 90% of clinically significant cancer eliminated at 1 year, with 75-80% of men avoiding radical treatment for 6-10 years. The 12% who experience recurrence can undergo repeat focal therapy or progress to surgery/radiotherapy with outcomes comparable to primary treatment. Long-term randomized trials comparing focal therapy to prostatectomy are underway, but current data supports focal therapy as definitive treatment for MRI-visible, intermediate-risk disease.

      Cancer Control Evidence

      • 90% clinically significant cancer eliminated at 1 year
      • 75-80% avoid radical treatment for 6-10 years
      • 12% recurrence rate (treatable with multiple options)
      • Equivalent outcomes to radical treatments for localized disease
      • Long-term randomized trials underway
      • Current data: definitive treatment for MRI-visible disease

      Educational Video Library (28 Videos - Complete Catalog)

      Comprehensive video education organized into 7 topical categories

      Total Videos: 28 VideoObjects with full metadata

      All Videos: Include transcripts, author attribution, duration, thumbnails

      Publisher: The Focal Therapy Clinic

      Language: en-GB

      Category 1: General Prostate Cancer Education (6 Videos)

      Video 1: Do only old men get prostate cancer?

      Video ID: #video-lo51o5xp9go

      YouTube Video ID: LO51O5xp9go

      Title: Mr Alan Doherty: Do only old men get prostate cancer?

      Author: Mr. Alan Doherty (Consultant Urologist)

      Author ID: https://www.thefocaltherapyclinic.co.uk/about-us/our-consultants/mr-alan-doherty/#person

      Duration: 35 seconds (PT35S)

      Upload Date: 2025-02-13T11:15:23Z

      Thumbnail URL: https://i.ytimg.com/vi/LO51O5xp9go/mqdefault.jpg

      Content URL: https://www.youtube.com/watch?v=LO51O5xp9go

      Embed URL: https://www.youtube-nocookie.com/embed/LO51O5xp9go

      Description: Mr. Alan Doherty (Consultant Urologist, The Focal Therapy Clinic): Prostate cancer is rare under 40 but occurs in all age groups above this. Since it can take time to become aggressive, age is an important factor in treatment decisions. Understanding the risks and timelines can help patients make informed choices about their care.

      Key Topics: Age and prostate cancer risk, age-related treatment decisions, prostate cancer in younger men

      Transcript Available: Yes (full transcript in schema)

      Video 2: How many people are diagnosed with prostate cancer every year?

      Video ID: #video-statistics-annual

      Title: Annual Prostate Cancer Diagnosis Statistics

      Content: Epidemiology data on prostate cancer incidence in the UK and globally

      Key Topics: Prostate cancer statistics, diagnosis rates, prevalence data

      Video 3: Is prostate cancer a 'good' cancer to get?

      Video ID: #video-good-cancer

      Title: Is Prostate Cancer a 'Good' Cancer?

      Content: Consultant perspective on prostate cancer prognosis, survival rates, and treatment outcomes

      Key Topics: Cancer prognosis, survival rates, disease characteristics, treatment success

      Video 4: What is the prognosis for prostate cancer?

      Video ID: #video-prognosis

      Title: Prostate Cancer Prognosis Explained

      Content: Detailed explanation of prognosis factors, survival statistics, and outcome predictors

      Key Topics: Prognosis factors, survival statistics, Gleason score impact, PSA levels

      Video 5: What are the symptoms of prostate cancer?

      Video ID: #video-symptoms

      Title: Prostate Cancer Symptoms and Warning Signs

      Content: Explanation of common symptoms, urinary changes, and when to seek medical attention

      Key Topics: Symptoms, warning signs, urinary issues, early detection

      Video 6: What is the prostate and what does it do?

      Video ID: #video-prostate-anatomy

      Title: Prostate Anatomy and Function

      Content: Anatomical explanation of prostate gland, its role in male reproductive system

      Key Topics: Prostate anatomy, gland function, male reproductive health

      Category 2: Diagnosis and Testing (4 Videos)

      Video 7: What is a prostate cancer lesion?

      Video ID: #video-lesion-explained

      Title: Understanding Prostate Cancer Lesions

      Content: Explanation of lesions, MRI detection, PIRADS scoring

      Key Topics: Lesions, MRI imaging, PIRADS scores, tumor localization

      Video 8: Should you have your PSA measured?

      Video ID: #video-psa-screening

      Title: PSA Testing - Should You Get Screened?

      Content: Consultant guidance on PSA screening benefits, limitations, decision-making

      Key Topics: PSA testing, screening guidelines, early detection, PSA limitations

      Video 9: Is a PSA test reliable?

      Video ID: #video-psa-reliability

      Title: PSA Test Reliability and Accuracy

      Content: Explanation of PSA test accuracy, false positives/negatives, interpretation

      Key Topics: PSA accuracy, false positives, test interpretation, confirmatory testing

      Video 10: How is prostate cancer diagnosed?

      Video ID: #video-diagnosis-process

      Title: Complete Prostate Cancer Diagnosis Process

      Content: Step-by-step diagnostic pathway from PSA through biopsy

      Key Topics: Diagnostic pathway, PSA, DRE, MRI, biopsy procedures

      Category 3: Treatment Options Overview (7 Videos)

      Video 11: What the treatment options are for prostate cancer

      Video ID: #video-treatment-overview

      Title: Complete Treatment Options for Prostate Cancer

      Content: Comprehensive overview of all treatment modalities from active surveillance through surgery

      Key Topics: Treatment options, focal therapy, surgery, radiotherapy, active surveillance, hormone therapy

      Video 12: What is radiotherapy for prostate cancer?

      Video ID: #video-radiotherapy

      Title: Radiotherapy for Prostate Cancer Explained

      Author: Dr. Christos Mikropoulos (Consultant Oncologist)

      Content: External beam radiation, side effects, treatment schedule, outcomes

      Key Topics: Radiotherapy, external beam radiation, side effects, treatment duration

      Video 13: Does focal therapy cure cancer?

      Video ID: #video-focal-cure

      Title: Does Focal Therapy Cure Prostate Cancer?

      Content: Explanation of focal therapy cancer control rates, success metrics

      Key Topics: Focal therapy efficacy, cancer control, cure rates, long-term outcomes

      Video 14: What is watchful waiting?

      Video ID: #video-watchful-waiting

      Title: Watchful Waiting vs Active Surveillance

      Content: Distinction between active surveillance and watchful waiting, candidacy

      Key Topics: Watchful waiting, active surveillance, monitoring protocols, candidacy

      Video 15: Is chemotherapy used for prostate cancer?

      Video ID: #video-chemotherapy

      Title: Chemotherapy for Prostate Cancer

      Content: When chemotherapy is used, advanced disease management

      Key Topics: Chemotherapy, advanced disease, metastatic prostate cancer, hormone-resistant cancer

      Video 16: Why have I been put on watchful waiting?

      Video ID: #video-why-watchful-waiting

      Title: Understanding Your Watchful Waiting Recommendation

      Content: Explanation of watchful waiting rationale, criteria, monitoring

      Key Topics: Watchful waiting rationale, patient selection, quality of life considerations

      Video 17: Brachytherapy for prostate cancer

      Video ID: #video-brachytherapy

      Title: Brachytherapy - Internal Radiation Therapy

      Author: Dr. Christos Mikropoulos (Consultant Oncologist)

      Content: Internal radiation seed implantation, procedure details, outcomes

      Key Topics: Brachytherapy, seed implantation, low-dose rate, high-dose rate, outcomes

      Category 4: Treatment Effectiveness (2 Videos)

      Video 18: Is focal therapy effective against prostate cancer?

      Video ID: #video-focal-effectiveness

      Title: Focal Therapy Effectiveness and Outcomes

      Content: Evidence-based outcomes, cancer control rates, quality of life preservation

      Key Topics: Focal therapy effectiveness, cancer control rates, outcome studies, quality of life

      Video 19: Do I need treatment for my prostate cancer?

      Video ID: #video-need-treatment

      Title: Do I Need Treatment? Active Surveillance vs Treatment

      Content: Decision-making guidance, risk stratification, treatment necessity

      Key Topics: Treatment necessity, risk assessment, active surveillance candidacy, decision support

      Category 5: Demographics and Risk Factors (3 Videos)

      Video 20: Are black men more likely to get prostate cancer?

      Video ID: #video-black-men-risk

      Title: Prostate Cancer Risk in Black Men

      Content: Ethnicity-related risk factors, screening recommendations, disparities

      Key Topics: Ethnicity, Black men risk, screening guidelines, health disparities

      Video 21: Do more black men get prostate cancer?

      Video ID: #video-black-men-incidence

      Title: Prostate Cancer Incidence in Black Men

      Content: Epidemiology, incidence rates, screening importance

      Key Topics: Incidence rates, ethnicity factors, early screening importance

      Video 22: Can young men get prostate cancer?

      Video ID: #video-young-men

      Title: Prostate Cancer in Younger Men

      Content: Prostate cancer in men under 50, risk factors, treatment considerations

      Key Topics: Young-onset prostate cancer, age factors, aggressive disease, treatment options

      Category 6: Advanced Disease (2 Videos)

      Video 23: What is advanced prostate cancer?

      Video ID: #video-advanced-cancer

      Title: Understanding Advanced Prostate Cancer

      Content: Definition of advanced disease, metastatic spread, treatment options

      Key Topics: Advanced disease, metastatic cancer, staging, treatment approaches

      Video 24: How long can I live with prostate cancer?

      Video ID: #video-life-expectancy

      Title: Life Expectancy with Prostate Cancer

      Content: Survival statistics by stage, prognosis factors, quality vs quantity of life

      Key Topics: Life expectancy, survival rates, prognosis, quality of life

      Category 7: Patient Decision-Making (4 Videos)

      Video 25: Is prostate cancer genetic?

      Video ID: #video-genetic-risk

      Title: Genetic Factors in Prostate Cancer

      Content: Family history, genetic testing, hereditary risk

      Key Topics: Genetics, family history, hereditary risk, genetic testing

      Video 26: Is prostate cancer curable?

      Video ID: #video-curable

      Title: Is Prostate Cancer Curable?

      Content: Cure rates by stage, treatment success, long-term outcomes

      Key Topics: Curability, treatment success rates, localized vs advanced disease

      Video 27: Can I prevent prostate cancer?

      Video ID: #video-prevention

      Title: Prostate Cancer Prevention Strategies

      Content: Risk reduction strategies, diet, lifestyle, screening

      Key Topics: Prevention, risk reduction, diet, lifestyle factors, screening

      Video 28: Why you need a prostate cancer second opinion

      Video ID: #video-second-opinion

      Title: The Importance of a Second Opinion

      Content: Value of second opinions, treatment alternatives, informed decision-making

      Key Topics: Second opinions, treatment alternatives, decision support, patient empowerment

      Diagnostic Testing Information

      PSA Testing (Prostate-Specific Antigen)

      Test Type: Blood test measuring PSA protein levels

      Normal Range: Typically <4 ng/mL (varies by age)

      Elevated PSA: May indicate prostate cancer, BPH, prostatitis, or other conditions

      Limitations: Not specific to cancer, false positives common

      Follow-up: MRI scan typically recommended for elevated PSA

      Monitoring: Regular PSA tests track disease progression or recurrence

      Multiparametric MRI Scan (mpMRI)

      Imaging Type: Advanced MRI combining multiple parameters

      Purpose: Visualize prostate cancer lesions, guide biopsy

      Scoring System: PIRADS (Prostate Imaging-Reporting and Data System)

      PIRADS 1-2: Low likelihood of clinically significant cancer

      PIRADS 3: Equivocal

      PIRADS 4-5: High likelihood of clinically significant cancer

      Benefit: Identifies tumor location for targeted biopsy and treatment planning

      Prostate Biopsy

      Types: Transrectal biopsy, Transperineal biopsy (preferred), MRI fusion biopsy

      Transperineal: Through skin between scrotum and anus, lower infection risk

      Fusion Biopsy: MRI images fused with real-time ultrasound for targeted sampling

      Samples: Typically 12-24 core samples taken

      Analysis: Gleason score assigned based on cancer grade

      Accuracy: MRI-targeted biopsy more accurate than systematic biopsy

      Gleason Score Grading

      Grading System: Microscopic cancer grade based on cell pattern

      Score Range: 6 (3+3) to 10 (5+5)

      Grade Group 1: Gleason 6 (3+3) - Lowest risk

      Grade Group 2: Gleason 7 (3+4) - Intermediate favorable risk

      Grade Group 3: Gleason 7 (4+3) - Intermediate unfavorable risk

      Grade Group 4: Gleason 8 (4+4, 3+5, 5+3) - High risk

      Grade Group 5: Gleason 9-10 (4+5, 5+4, 5+5) - Highest risk

      Impact: Primary factor in treatment decision-making

      Patient Decision Support Framework

      Key Decision Factors

      Modern Treatment Philosophy

      Treatment Ladder Approach: Start with least invasive option preserving quality of life

      Questions to Ask Your Consultant

      Medical Keywords and Topics

      Primary Medical Condition

      Prostate Cancer (Prostatic Carcinoma)

      Localized Prostate Cancer

      ICD-10 Code: C61

      Treatment Keywords

      Diagnostic Keywords

      Clinical Outcome Keywords

      Treatment Comparison Keywords

      Candidacy and Eligibility Keywords

      Regulatory and Approval Keywords

      Risk Factor Keywords

      Advanced Disease Keywords

      Patient Support Keywords

      Regulatory Codes and Medical Standards

      ICD-10 Medical Coding

      Code: C61

      Description: Malignant neoplasm of prostate

      Coding System: ICD-10 (International Classification of Diseases, 10th Revision)

      NICE Interventional Procedure Guidance

      HIFU Approval

      Code: IPG118

      Full Name: High-intensity focused ultrasound for prostate cancer

      Reference URL: https://www.nice.org.uk/guidance/ipg118

      Status: Approved for use in NHS

      NanoKnife IRE Approval

      Code: IPG424

      Full Name: Irreversible electroporation for treating prostate cancer

      Reference URL: https://www.nice.org.uk/guidance/ipg424

      Status: Approved for use in NHS

      Professional Medical Bodies

      Medical Specialty Classification

      Primary Specialty: Urology

      Wikidata Reference: https://www.wikidata.org/wiki/Q177005

      Related Specialty: Oncology (radiotherapy, chemotherapy)

      Schema Technical Metadata

      Schema Blocks Summary

      Total Schema Blocks: 4 comprehensive JSON-LD implementations

      Total Lines: 5,533 lines in source file

      Schema Vocabulary: schema.org

      Primary Schema Types: MedicalWebPage, WebSite, Organization, BreadcrumbList, FAQPage, Person, MedicalProcedure, VideoObject, ItemList

      Block 1: Yoast SEO Schema Graph (Line 57)

      Block 2: FAQPage Schema (Lines 1012-1087)

      Block 3: Extended Medical Web Page Schema (Lines 1090-1263)

      Block 4: Video Playlist Schema (Lines 3560-4417)

      Unique Schema Features

      E-E-A-T Signal Strength

      Search Engine Feature Eligibility

      This page is eligible for the following search features:

      Content Quality and Medical Information

      Content Freshness Indicators

      Content Depth and Comprehensiveness

      Medical Accuracy and Credibility

      User Intent Served

      This hub page comprehensively serves multiple user intents:

      Audience Segmentation

      Social Media and Sharing Optimization

      Open Graph (Facebook, LinkedIn)

      Twitter Card

      Video Content for Sharing

      Implementation Recommendations

      Strengths (Already Implemented)

      Potential Enhancements (Optional)

      Maintenance Schedule Recommendations

      Page Analytics Tracking Suggestions

      Suggested Metrics to Track

      User Journey Insights

      Conversion Funnel

      Medical Disclaimer and Compliance

      Medical Disclaimer

      Content Disclaimer: This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

      Data Accuracy Standards

      Regulatory Compliance

      Competitive Advantages

      Educational Content Leadership

      Medical Authority Signals

      Patient-Centric Approach

      Technical Excellence

      Transparency